Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.0450 (-2.08%) ($7.0450 - $7.0450) on Tue. Dec. 29, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.33% (three month average) | RSI | 45 | Latest Price | $7.0450(-2.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -3.2% a day on average for past five trading days. | Weekly Trend | BCRX declines -3.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(43%) IBB(38%) IWO(37%) IWC(36%) IWM(36%) | Factors Impacting BCRX price | BCRX will decline at least -2.665% in a week (0% probabilities). VIXM(-19%) UUP(-13%) VXX(-8%) IGOV(-4%) TBT(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.665% (StdDev 5.33%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.33 | 5 Day Moving Average | $7.33(-3.89%) | 10 Day Moving Average | $7.79(-9.56%) | 20 Day Moving Average | $7.33(-3.89%) | To recent high | -17.4% | To recent low | 39.9% | Market Cap | $1.243b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |